KalVista Pharmaceuticals (KALV) Revenue (2014 - 2025)
KalVista Pharmaceuticals recorded quarterly Revenue of $57.0 million in Q3 2025, up 418.18% quarter-over-quarter from $11.0 million in Q2 2025.
KalVista Pharmaceuticals' Revenue history runs 8 years deep, the most recent figure standing at $57.0 million for Q3 2025.
- In Q3 2025, Revenue changed N/A year-over-year to $57.0 million; the TTM figure through Jul 2025 stood at $71.8 million (up 670.56% YoY), while the FY2025 annual figure was $11.0 million, down 78.0% from the prior year.
- Revenue came in at $57.0 million for Q3 2025 at KalVista Pharmaceuticals, up from $11.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $57.0 million in Q3 2025 to a low of $11.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 57.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 57.00 Mn |
| Apr 30, 2025 | 11.00 Mn |
| Apr 30, 2020 | 3.82 Mn |
| Jan 31, 2020 | 1.58 Mn |
| Oct 31, 2019 | 3.92 Mn |
| Jul 31, 2019 | 3.37 Mn |
| Apr 30, 2019 | 2.93 Mn |
| Jan 31, 2019 | 3.89 Mn |
| Oct 31, 2018 | 5.59 Mn |
| Jul 31, 2018 | 3.72 Mn |
| Apr 30, 2018 | 4.84 Mn |
| Jan 31, 2018 | 2.33 Mn |
| Oct 31, 2017 | 1.13 Mn |
| Jul 31, 2017 | 96,000.00 |
| Apr 30, 2017 | 114,000.00 |
| Jan 31, 2017 | 248,000.00 |
| Oct 31, 2016 | 197,000.00 |
| Jul 31, 2016 | 975,000.00 |
| Mar 31, 2016 | 7,000.00 |
| Dec 31, 2015 | 7,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Jun 30, 2015 | 7,000.00 |
| Mar 31, 2015 | 7,000.00 |
| Dec 31, 2014 | 8,000.00 |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 5,000.00 |
| Mar 31, 2014 | 6,000.00 |